Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
Drug Insights
4 min read
Exploring Lorlatinib's Revolutionary R&D Successes
20 September 2023
This article summarized the latest R&D progress of Lorlatinib, the Mechanism of Action for Lorlatinib, and the drug target R&D trends for Lorlatinib.
Latest Hotspot
3 min read
The first patient of Vincerx Pharma's Phase 1 Clinical Tria of VIP943 has been administered
20 September 2023
Vincerx Pharma, Inc. declared that the initial patient in the Phase 1 clinical trial has received treatment with VIP943.
Drug Insights
4 min read
Decoding Iloperidone: A Comprehensive Study of its R&D Trends
20 September 2023
This article summarized the latest R&D progress of Iloperidone, the Mechanism of Action for Iloperidone, and the drug target R&D trends for Iloperidone.
Valuable Targets
6 min read
Progress in the Study of HIV-1 Integrase Inhibitors
20 September 2023
HIV-1 integrase is an enzyme that plays a crucial role in the replication of the human immunodeficiency virus (HIV-1) within the human body.
Drug Insights
3 min read
Deep Scientific Insights on Idarucizumab's R&D Progress
20 September 2023
This article summarized the latest R&D progress of Idarucizumab, the Mechanism of Action for Idarucizumab, and the drug target R&D trends for Idarucizumab.
Latest Hotspot
3 min read
Oscotec/ ADEL reveal FDA has granted the IND application clearance for ADEL-Y01 to treat Alzheimer's Disease
20 September 2023
Oscotec Inc. and ADEL Inc. has announced that the FDA has given the IND application approval for ADEL-Y01 to be used in the treatment of Alzheimer's Disease.
Drug Insights
5 min read
An In-depth Analysis of Glofitamab's R&D Progress and Mechanism of Action on Drug Target
20 September 2023
This article summarized the latest R&D progress of Glofitamab, the Mechanism of Action for Glofitamab, and the drug target R&D trends for Glofitamab
Valuable Targets
7 min read
Advances in the Application of HER2 Inhibitors in Tumors
20 September 2023
Human Epidermal Growth Factor Receptor 2 (HER2) is a member of the EGFR kinase family, which also includes HER1, HER3, and HER4.
Drug Insights
4 min read
Fezolinetant: Detailed Review of its Transformative R&D Success
20 September 2023
This article summarized the latest R&D progress of Fezolinetant, the Mechanism of Action for Fezolinetant, and the drug target R&D trends for Fezolinetant.
Latest Hotspot
3 min read
Nektar Therapeutics Reports Encouraging Preliminary Results from Phase 1b Trial of Rezpegaldesleukin
20 September 2023
Nektar Therapeutics disclosed fresh clinical results concerning rezpegaldesleukin utilised for patients battling atopic dermatitis, featuring new clinical effectiveness parameters from its Phase 1b research.
Drug Insights
4 min read
Faricimab Unveiled: A Detailed Overview of its Revolutionary R&D Breakthroughs
20 September 2023
This article summarized the latest R&D progress of Faricimab, the Mechanism of Action for Faricimab, and the drug target R&D trends for Faricimab.
Valuable Targets
5 min read
Review and Prospects of HDAC Inhibitors
20 September 2023
HDAC (Histone Deacetylase), otherwise known as a histone deacetylase, is an important type of enzyme involved in the process of histone modifications.